SecBot SecBot

ZVSA

ZyVersa Therapeutics, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001859007 Biotech & Drug Discovery
$0.001000 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.001000
Next earnings
Nov 17
in 21 days
1 year
−99.3%
from $0.1460 · Oct 28
30 days
−99.0%
from $0.1030
52-week range
$0.001000–0.2700
−100% from high · low Oct 20
Avg volume 20D
21.0K
Oct 13 spike 216.2K
Short interest
138.4K
−2.3%
Days to cover
1.8
at average volume
New fund stakes
0
Q2 2025 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 17, 2026
Strongest BEARISH ZyVersa Therapeutics (ZVSA) downlisted from the OTCQB Venture Market to the OTC Pink Limited Market…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2025: 1 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest −2.3% to 138.4K shares. 1.8 days to cover.

  • TrendDOWNTREND

    99% below its 50-day average. New closing low $0.001000 on Oct 26.

Who's buying

13F· Q2 2025
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD39,280$26.6K
UBS Group AGDOUBLED28,327$17.8K
UBS Group AGDOUBLED4,187$4.4K
BANK OF AMERICA CORP /DE/DOUBLED109$115.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2024
Recent actions
DateFirmActionRating
Mar 26, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Mar 12, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Feb 29, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy

Earnings setup

Estimates
Nov 17
reports in 21 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 Earnings calendar
ZVSA Q2 2026 Earnings Scheduled — 2026-10-02
Jul 16, 2026 SEC
ZyVersa Therapeutics (ZVSA) downlisted from the OTCQB Venture Market to the OTC Pink Limited Market effective July 16…
8-K — Impact 5/10
Mar 5, 2026 SEC
ZyVersa Therapeutics raised $1 million through a private placement of convertible promissory notes and warrants to…
8-K — Impact 4/10
Jun 30, 2025 Inst.
UBS Group AG — ADD
39,280 shares ($26.6K)
Mar 31, 2025 Inst.
UBS Group AG — DOUBLED
28,327 shares ($17.8K)

Short side

FINRA· Oct 15, 2026
138,394
shares short
-2.3%
vs prior settlement
1.8
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
ZVSA Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Oct 2, 2026
Earnings date
ZVSA Q2 2026 Earnings Scheduled — 2026-10-02
Aug 27, 2026
Earnings date
ZVSA Q2 2026 Earnings Scheduled — 2026-08-27
Aug 11, 2026
Earnings date
ZVSA Q2 2026 Earnings Scheduled — 2026-08-11
May 13, 2026
Earnings date
ZVSA Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
Earnings date
ZVSA Q1 2026 Earnings Scheduled — 2026-05-11

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All ZVSA filing & press-release reports (2)